Mark Vanderkelen
Mark Vanderkelen publishes mostly in Neurology, Oncology and Public Health, Environmental and Occupational Health, on topics such as Myasthenia Gravis and Thymoma, Cancer Treatment and Pharmacology and Pregnancy and Medication Impact.
- World rank
- #2,574,713 of 7,710,434 ranked researchers
- Rank in Belgium
- #23,378 of 67,186
- Works
- 19
- Citations
- 362
- Citations per work
- 19.1
What does Mark Vanderkelen research?
Mark Vanderkelen's work is mostly in Medicine (63%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1262.7%
- Medicine1262.7%
- Everything else629.5%
- Life Sciences17.8%
- 1Neurology26% of their works
- 2Oncology14% of their works
- 3Public Health, Environmental and Occupational Health10% of their works
- 4Immunology8% of their works
- 5Endocrinology, Diabetes and Metabolism8% of their works
- 6Orthopedics and Sports Medicine6% of their works
Research topics
Which keywords describe Mark Vanderkelen's research?
The keywords of their largest research topics: Epidemiology, Myasthenia Gravis, Thymic Tumors, Chemotherapy-Induced Peripheral Neuropathy, Medication Use, Pregnancy, Taxanes and Decidual NK Cells.
- Cushing's Syndrome
- Fractures
- Diagnosis
- Bone Mineral Density
- Decidual NK Cells
- Pregnancy
- Chemotherapy-Induced Peripheral Neuropathy
- Myasthenia Gravis
- Epidemiology
- Thymic Tumors
- Medication Use
- Taxanes
- Regulatory T Cells
- Camptocormia
- Eosinophilic Esophagitis
- Parkinson's Disease
- Pituitary Adenomas
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Epidemiology122 topics
- Myasthenia Gravis91 topic
- Thymic Tumors91 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Medication Use51 topic
- Pregnancy51 topic
- Taxanes51 topic
- Decidual NK Cells41 topic
- Regulatory T Cells41 topic
- Bone Mineral Density31 topic
- Camptocormia31 topic
- Diagnosis31 topic
- Eosinophilic Esophagitis31 topic
- Fractures31 topic
- Parkinson's Disease31 topic
- Cushing's Syndrome21 topic
- Pituitary Adenomas21 topic
Where does Mark Vanderkelen work?
Mark Vanderkelen's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Mark Vanderkelen have?
OpenAlex counts 19 works and 362 citations for Mark Vanderkelen, an h-index of 6, ranking #2,574,713 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Vanderkelen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.